Industry landscapes
The companies, capital and talent shaping healthtech in Germany. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
Recently founded means a recorded 2023–2026 founding year and no recorded parent, acquirer or public-company status. These companies are not labelled startups without that separate classification.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
313 of 3,349 tracked companies have open roles.
459 of 3,349 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 509 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 35.4% of disclosed capital, while 86.3% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $218.33M | 152 | 34 |
| 2017 | $162.54M | 160 | 30 |
| 2018 | $176.24M | 135 | 37 |
| 2019 | $255.55M | 161 | 45 |
| 2020 | $226.47M | 223 | 51 |
| 2021 | $458.32M | 160 | 49 |
| 2022 | $649.02M | 120 | 59 |
| 2023 | $346.27M | 85 | 42 |
| 2024 | $368.56M | 38 | 35 |
| 2025 | $582.8M | 12 | 27 |
Share of all disclosed company funding.
756 recorded rounds since 2016
Recorded participation in healthtech company rounds since 2016.
Backed by .
Backed by Bmp Ventures and IBG Beteiligungsgesellschaft Sachsen-Anhalt and others.
Backed by .
Backed by 4impact and Hanno Renner and others.
Backed by Verdane.
Backed by Fresenius and SAP.
Backed by 3TS Capital Partners and Grazia Equity and others.
Backed by YZR Capital and DN Capital and others.
Participating investors were not recorded in this snapshot.
Backed by KIRKBI A/S and M&G and others.
Backed by GE Capital and UBS and others.
Backed by DeNA and SEIBU REAL ESTATE.
Participating investors were not recorded in this snapshot.
Participating investors were not recorded in this snapshot.
Backed by Samsung Catalyst Fund and Vitruvian Partners and others.
Backed by Hg.
Backed by EQT and Gimv and others.
Backed by Balderton Capital and Heal Capital and others.
The measured Germany identity-to-filing probe did not produce a qualifying designated legal or national-ID join: designated German registry identities do not carry the LEI or ISIN used by bundesanzeiger facts; legal-name matching is prohibited.
How the Germany companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
51 of the 3,349 companies on this page carry a measured traffic record (1.5%); these are the largest of those, by monthly visits. The median among them is 172,994 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| Doctolib GmbHdoctolib.de | 10,592,484 | 70 | 78.4% |
| DocCheckdoccheck.com | 5,135,994 | 83 | 65.9% |
| AMBOSSamboss.com | 4,393,203 | 62 | 8.6% |
| DocMorrisdocmorris.de | 3,423,614 | 61 | 74.9% |
| Kenhubkenhub.com | 3,000,294 | 81 | 41.7% |
| Jamedajameda.de | 2,401,723 | 65 | 78.6% |
| Medikamente-Per-Klickmedikamente-per-klick.de | 1,643,758 | 66 | 77.3% |
| Medizinfuchsmedizinfuchs.de | 1,553,062 | 59 | 76.9% |
| Cluehelloclue.com | 1,355,713 | 65 | 88.4% |
| medpexmedpex.de | 1,184,750 | 55 | 77.6% |
Visits and authority are third-party web estimates, not company-reported figures.
465 of these companies (13.9%) publish at least one Android app — 804 apps in all, carrying 161.9M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| Clue Cycle & Period TrackerClue | 68.5M | 4.5 | Health & Fitness |
| Weight Tracker: BMI CalculatorAkti BMI | 13.1M | 4.4 | Health & Fitness |
| Ada - your health portalAda | 11.5M | 4.6 | Medical |
| Meds & Pill Reminder MyTherapyMyTherapy | 9.5M | 4.6 | Medical |
| DocMorris Apotheke & E-RezeptDocMorris | 3.3M | 4.5 | Medical |
| Memorado - Brain GamesMemorado | 3.2M | 3.9 | Education |
| Endel: Focus, Relax & SleepEndel | 2.6M | 4 | Health & Fitness |
| 7Mind: Meditation & Sleep7Mind | 2.3M | 4 | Health & Fitness |
| SnoreClock - Do you snore?Ralph\'s Apps | 2.1M | 4.7 | Health & Fitness |
| MindDoc: Mental Health SupportMindDoc | 1.9M | 4.2 | Health & Fitness |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Disease Self Management | 207 | 127.4M | Clue Cycle & Period Tracker 68.5M | |
| Fitness & Wellness Tech | 27 | 21.1M | Weight Tracker: BMI Calculator 13.1M | |
| Healthcare Booking Platforms | 111 | 19.7M | DocMorris Apotheke & E-Rezept 3.3M | |
| Healthcare It | 417 | 16M | Das E-Rezept 1.7M | |
| Chatbots | 3 | 11.5M | Ada - your health portal 11.5M | |
| Continued Learning | 29 | 5.7M | Memorado - Brain Games 3.2M | |
| Wearable Technology | 45 | 4.6M | SnoreClock - Do you snore? 2.1M | |
| Artificial Intelligence | 10 | 2.6M | Endel: Focus, Relax & Sleep 2.6M |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 437 of 804 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
161 companies hiring · $4.4B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Curaleaf Holdings has completed the buyout of the remaining 45% stake in Four 20 Pharma GmbH.
Germany-based Aignostics is applying artificial intelligence to drug development, aiming to improve both efficiency and patient outcomes.
brainjo raised €2M seed round for VR ADHD Therapy.
Munich-based digital health startup XO Life has closed a new €4 million funding round.
Insight Health secured $11 million in a Series A round led by Standard Capital, with participation from Pear VC, Kindred Ventures, Eudemian, ElevenLabs, and 43.
Osborne Clarke has provided legal advice to Schweizerische Post AG on its participation in the extended seed financing round of the Munich HR-Tech company heycare of around EUR 4 million.
The MedTech Spin-Off RAYDIAX has raised a total of 7.5 million euros to advance clinical validation and market entry of its therapy assistant computer tomograph TACT.
International business law firm Osborne Clarke has provided legal advice to SwissHealth Ventures, the venture capital arm of the Swiss health insurance CSS, and Belgian investor Capricorn Partners on a seed financing round of EUR 11 million from Frankfurt's Healthtech start-up Oska Health. Capricorn Partners and Swiss Health Ventures led the round, and BMH, LBBW Venture Capital, Revent, GoHub Ventures and Aurum Impact were also involved.
Molecular cancer testing firm Mainz Biomed announced on Tuesday that it has entered into a securities purchase agreement for a $6.0 million private placement with investor David Lazar.
The healthtech company hellomed Group GmbH (Berlin) has successfully completed a financing round of 6 million euros.
Top 10 categories among 414 recorded events in the 24-month window.
3 companies with recorded IPO activity
IPO · Frankfurt Stock Exchange12 reports
IPO · Frankfurt6 reports
IPO · Nasdaq Capital Market1 reports
13 tracked people moves
Appointment Managing Director
Appointment Chairman of the Board of Directors
Appointment Chief Executive Officer
Appointment Chief Executive Officer
Appointment Site Head
Appointment Member of the Supervisory Board
Termination Previously Chief Executive Officer
Appointment Chief Executive Officer
Products, platforms and features in the recorded window
Packaging film/ bags
7 recorded customer wins
Customer: Waste Management
Customer: Florida waste transfer operator
Customer: Formycon AGPharmaceuticals
Customer: emsHealthcare
Customer: roche diagnosticsPharmaceuticals
Customer: Pall Corp.
2 companies with reported reductions
275 rolescost reduction
Scale not stated rolescost reduction
4 recorded events
approvedFDA
fully admitted to trading on regulated marketFrankfurt Stock Exchange
approved for acquisitionEuropean Union
relevant investigating authorities
1 tracked suits
patent litigations for EXPARELPatent · Settled
Reported company results in the recorded window.
Median across 57 reported growth observations; companies may contribute multiple periods.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| curaleaf→Four 20 Pharma ↗ | Completed | 2026-05-01 | Not stated in snapshot |
| essilorluxottica→Heidelberg Engineering ↗ | Completed | 2025-12-12 | Not stated in snapshot |
| Junginger Capital Affairs GmbH→AAT ↗ | 2025-12-09 | Not stated in snapshot | |
| funke medical→Deron B.V. | 2025-12-04 | Not stated in snapshot | |
| Smart Reporting→Fluency for Imaging | Announced | 2025-10-16 | Not stated in snapshot |
| Na→Siemens Healthineers ↗ | Rumored | 2025-09-12 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
1,323 postings in the preceding 12 months. The full 5,082-posting snapshot covers 170 employers.
49 tracked postings mention remote work.
1,454 postings specify a level.
Top skills across 5,082 tracked postings in the available jobs snapshot.
Median across 104 postings with pay data, expressed in USD.
| Company | Employees |
|---|---|
| B Braun ↗ | 64,000 |
| carl zeiss meditec ↗ | 4,224 |
| euroimmun ag ↗ | 3,500 |
| Auxilium ↗ | 2,352 |
| geers ↗ | 2,000 |
| Paul Hartmann ↗ | 1,776 |
| Otto Bock ↗ | 1,460 |
| Maquet Cardiopulmonary ↗ | 1,000 |
2,007 founders and chief executives across 1,359 companies.
Fresenius Medical Care North America, ex-Zimmer Biomet, ex-Pawtucket Medical Devices, University of California, Los Angeles - School of Law, 2018
Amboss, ex-Netempire, ex-Tompower, University of California, San Francisco, 2010
Ex-Jubii A/S, The Boston Consulting Group, Viagogo. University of Houston Law Center LL.M 1996…
Ex-CEO Epigenomics, AltheaDx, RGTN, Enigma Diagnostics, Hologic, Leo Burnett. Purdue University Daniels School of Business BS 1992…
Venture Partner - Speedinvest · Venture Partner - YZR Capital · Technical University of Munich Master of Science 2012
Ex-Founder HeavenHR, Bain & Company, Director Rocket Internet. University of Munster BS 2010, ESCP Europe MS 2013
Ex-Delivery Hero, SoundCloud, Rocket Internet. HSBA Hamburg School of Business Administration BA 2011, University of Cambridge MPhil & PhD
PAASP GmbH, Pavlov Medical University, Ex- Pharma Innovation Excellence (PHINNEX), AbbVie…
Founder Planerio. Berlin Neuroimaging Center MD 2007, Harvard School of Public Health 2013
Ex-ecadia · University of Stuttgart BS 2020, Hasso Plattner Institute MS 2021
Ex-Vend, Westpac New Zealand · CIM · The Chartered Institute of Marketing
G-Therapeutics, NLC Accelerating HealthTech Inventions, ex-Medtronic, Philips Research. Utrecht University PhD 1990
99 profiles with education records.
27 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
448,927 articles in the measured 12-month window.
Healthtech coverage across Germany · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 75,673 |
| 2021Q3 | 83,198 |
| 2021Q4 | 70,129 |
| 2022Q1 | 89,865 |
| 2022Q2 | 84,126 |
| 2022Q3 | 81,657 |
| 2022Q4 | 99,317 |
| 2023Q1 | 102,401 |
| 2023Q2 | 93,635 |
| 2023Q3 | 103,962 |
| 2023Q4 | 88,857 |
| 2024Q1 | 111,609 |
| 2024Q2 | 123,766 |
| 2024Q3 | 117,999 |
| 2024Q4 | 121,500 |
| 2025Q1 | 172,490 |
| 2025Q2 | 106,800 |
| 2025Q3 | 175,410 |
| 2025Q4 | 87,184 |
| 2026Q1 | 89,592 |
Article volume measures coverage, not market sales.
662 recorded company events across 89 companies; percentages use that event total.
Healthtech coverage across Germany · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
Healthtech coverage across Germany
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| countries | 4,193 | 1,858 | 126% |
| multilateral diplomacy | 1,592 | 1,065 | 49% |
| national security strategy | 958 | 618 | 55% |
| study overseas | 648 | 371 | 75% |
| overseas study | 588 | 344 | 71% |
| semester abroad | 528 | 308 | 71% |
| aerial bombardments | 520 | 184 | 183% |
| quarterly financials | 487 | 333 | 46% |
| oil price volatility | 464 | 164 | 183% |
| commodity futures | 431 | 215 | 100% |
| europa league | 438 | 2,238 | -80% |
| olympic team selections | 771 | 1,902 | -59% |
| nationalist composers | 3 | 1,889 | -100% |
| aleatoric music | 9 | 1,468 | -99% |
| quarterfinals | 378 | 1,332 | -72% |
Healthtech coverage across Germany
territories, disputed islands, countries
24.2% critical · 15.0% positiveinflation reports fx, currency intervention policies, eur/usd
41.2% critical · 43.6% positivegdp growth rate, gdp acceleration, economic output growth
29.5% critical · 46.3% positiveHealthtech coverage across Germany. Topic labels describe recorded classifications and can include broad context.
53,214 papers in the recorded worldwide scope.
Tone counts: 46,301 positive · 2,052 neutral · 4,861 negative.
Landmark: Implementation strategies: recommendations for specifying and reporting
Landmark: Deep Learning for Health Informatics
Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
Common problems researchers identify · 0119.0% of this theme group
Examines challenges and strategies for building resilient health care delivery and administration.
Health informatics (400) · Health administration (281) · Nursing research (250) · Public health (273)
Resilient Health Care: a systematic review of conceptualisations, study methods and factors that develop resilience
Health systems resilience in practice: a scoping review to identify strategies for building resilience
| Year | Share index |
|---|---|
| 2022 | 23.2 |
| 2023 | 21.1 |
| 2024 | 27.6 |
| 2025 | 44.8 |
Common problems researchers identify · 0218.9% of this theme group
Highlights difficulties in multi‑target discovery, repurposing, and regulatory pathways for new therapeutics.
Drug discovery (321) · Drug (197) · Drug development (103) · Disease (155)
A perspective on multi‐target drug discovery and design for complex diseases
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
| Year | Share index |
|---|---|
| 2022 | 157.3 |
| 2023 | 161.8 |
| 2024 | 169.7 |
| 2025 | 211.5 |
Common problems researchers identify · 0315.9% of this theme group
Discusses barriers to adopting eHealth tools and their impact on universal health coverage.
Digital health (627) · Health care (357) · Digital transformation (69) · eHealth (97)
Technology and Universal Health Coverage: Examining the role of digital health
Engagement With and Acceptability of Digital Media Platforms for Use in Improving Health Behaviors Among Vulnerable Families: Systematic Rev
| Year | Share index |
|---|---|
| 2022 | 538.7 |
| 2023 | 553.0 |
| 2024 | 540.4 |
| 2025 | 843.9 |
Common problems researchers identify · 0414.7% of this theme group
Analyzes practical and methodological obstacles to scaling telemedicine and telerehabilitation services.
Telemedicine (604) · Telehealth (394) · Health care (334) · Telerehabilitation (53)
Opportunities and challenges for telehealth within, and beyond, a pandemic
Strategies for Evaluating Telehealth
| Year | Share index |
|---|---|
| 2022 | 542.2 |
| 2023 | 554.7 |
| 2024 | 541.1 |
| 2025 | 844.0 |
Common problems researchers identify · 0511.7% of this theme group
Explores limits of personalized cancer diagnostics, biomarker validation, and drug resistance.
Precision medicine (480) · Personalized medicine (238) · Disease (116) · Precision oncology (28)
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
Personalizing Oncology: Perspectives and Prospects
| Year | Share index |
|---|---|
| 2022 | 1255.2 |
| 2023 | 1115.6 |
| 2024 | 1012.0 |
| 2025 | 1296.9 |
Common problems researchers identify · 0610.9% of this theme group
Addresses safety, risk analysis, and regulatory gaps for emerging wearable and device technologies.
Medical device (221) · Wearable computer (50) · Medical equipment (27) · Risk analysis (34)
Energy sources and their development for application in medical devices
Medical Devices and Health — Creating a New Regulatory Framework for Moderate-Risk Devices
| Year | Share index |
|---|---|
| 2022 | 40.4 |
| 2023 | 42.2 |
| 2024 | 43.7 |
| 2025 | 72.1 |
Common problems researchers identify · 078.8% of this theme group
Investigates how COVID‑19 reshaped telehealth usage and highlighted systemic weaknesses.
Pandemic (394) · Coronavirus disease 2019 (274) · 2019-20 coronavirus outbreak (69) · Telemedicine (258)
Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study
Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys
| Year | Share index |
|---|---|
| 2022 | 655.3 |
| 2023 | 440.6 |
| 2024 | 327.7 |
| 2025 | 212.1 |
Cautions · 0119.8% of this theme group
Calls for careful evaluation of effectiveness and patient satisfaction in remote care models.
Telemedicine (762) · Telehealth (476) · Telerehabilitation (118) · Health care (319)
The Role of Telemedicine in Improving Healthcare Outcome: A Review
Assessing the Efficiency and Patient Satisfaction of Telemedicine in Managing Chronic Health Conditions
| Year | Share index |
|---|---|
| 2022 | 51.7 |
| 2023 | 48.4 |
| 2024 | 44.2 |
| 2025 | 63.5 |
Cautions · 0219.8% of this theme group
Warns of implementation hurdles and quality‑assessment challenges for digital tools in low‑resource settings.
Health informatics (239) · Health administration (157) · Nursing research (113) · Medical device (92)
Challenges of using e-health technologies to support clinical care in rural Africa: a longitudinal mixed methods study exploring primary hea
Development and analysis of quality assessment tools for different types of patient information – websites, decision aids, question prompt l
| Year | Share index |
|---|---|
| 2022 | 23.2 |
| 2023 | 21.1 |
| 2024 | 27.6 |
| 2025 | 44.8 |
Cautions · 0315.3% of this theme group
Notes regulatory and predictive difficulties in applying genetic biomarkers to drug development.
Drug discovery (202) · Drug (160) · Pharmacogenomics (109) · Pharmacogenetics (64)
Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologic
| Year | Share index |
|---|---|
| 2022 | 154.6 |
| 2023 | 158.9 |
| 2024 | 165.9 |
| 2025 | 206.7 |
Cautions · 0414.7% of this theme group
Highlights variable efficacy, user experience, and ethical concerns of digital psychological interventions.
Digital health (480) · Psychological intervention (265) · Mental health (159) · Health care (262)
Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review
Digital Health Interventions for Promoting Healthy Aging: A Systematic Review of Adoption Patterns, Efficacy, and User Experience
| Year | Share index |
|---|---|
| 2022 | 790.2 |
| 2023 | 807.5 |
| 2024 | 810.9 |
| 2025 | 1159.7 |
Cautions · 0511.2% of this theme group
Examines clinician perspectives and adoption barriers specific to pandemic‑era remote services.
Pandemic (431) · Coronavirus disease 2019 (360) · Telemedicine (348) · 2019-20 coronavirus outbreak (77)
Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study
Exploring Ophthalmologists’ Adoption of Telemedicine during the COVID-19 Pandemic: A Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 544.1 |
| 2023 | 376.7 |
| 2024 | 243.3 |
| 2025 | 191.2 |
Cautions · 0610.3% of this theme group
Points out gaps in awareness, understanding, and equitable uptake of personalized oncology treatments.
Precision medicine (249) · Personalized medicine (164) · Cancer (103) · Oncology (57)
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Sur
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review
| Year | Share index |
|---|---|
| 2022 | 767.8 |
| 2023 | 1043.6 |
| 2024 | 798.0 |
| 2025 | 771.4 |
Cautions · 078.8% of this theme group
Raises ethical and reliability issues surrounding artificial‑intelligence applications in precision medicine.
Applications of artificial intelligence (102) · Transformative learning (77) · Health care (188) · Precision medicine (102)
Artificial intelligence in healthcare: revolutionizing precision medicine, predictive analytics, and ethical considerations in autonomous di
Artificial Intelligence in Medicine: Transforming Diagnosis, Treatment, and Healthcare Delivery
| Year | Share index |
|---|---|
| 2022 | 534.7 |
| 2023 | 549.6 |
| 2024 | 538.1 |
| 2025 | 839.2 |
Opportunities · 0118.0% of this theme group
Identifies promising frameworks for improving clinical usability and integration of digital health tools.
Digital health (282) · Health care (348) · Health informatics (142) · Psychological intervention (156)
Development of an Evidence-Based Conceptual Model of the Health Care Sector Under Digital Transformation: Integrative Review
HCI-modelling for improving the clinical usability of digital health technologies
| Year | Share index |
|---|---|
| 2022 | 541.3 |
| 2023 | 554.6 |
| 2024 | 543.2 |
| 2025 | 853.3 |
Opportunities · 0216.5% of this theme group
Highlights advances in computational docking and virtual screening for rapid therapeutic discovery.
Drug discovery (281) · In silico (99) · Drug (155) · Docking (85)
Exploring Cimetidine\nas a Potential Therapeutic Attenuator\nagainst Amyloid Formation in Parkinson’s Disease: Spectroscopic\nand Microscopi
Design, Synthesis,\nand Biological Evaluation of 5‑Formyl-pyrrolo[3,2‑<i>b</i>]pyridine-3-carboxamides as New Selective, Potent,
| Year | Share index |
|---|---|
| 2022 | 167.5 |
| 2023 | 172.4 |
| 2024 | 180.4 |
| 2025 | 218.9 |
Opportunities · 0313.8% of this theme group
Shows how molecular docking and chemical‑space exploration accelerate target‑focused drug design.
Drug discovery (536) · Computational biology (222) · Drug (224) · Chemical space (66)
Assessing molecular docking tools: understanding drug discovery and design
Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics
| Year | Share index |
|---|---|
| 2022 | 281.3 |
| 2023 | 298.1 |
| 2024 | 330.7 |
| 2025 | 367.6 |
Opportunities · 0413.7% of this theme group
Explores new telehealth applications for physical therapy and palliative‑care communication.
Telemedicine (475) · Telehealth (353) · Telerehabilitation (87) · Physical therapy (75)
Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study
Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations
| Year | Share index |
|---|---|
| 2022 | 51.7 |
| 2023 | 48.4 |
| 2024 | 44.2 |
| 2025 | 63.5 |
Opportunities · 0512.7% of this theme group
Describes emerging methods to tailor treatments using genomic heterogeneity across diseases.
Precision medicine (283) · Personalized medicine (216) · Disease (142) · Pharmacogenomics (61)
Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease
Deep Learning for Precision Medicine: Advancing Personalized Treatment Plans in Oncology
| Year | Share index |
|---|---|
| 2022 | 1255.2 |
| 2023 | 1115.6 |
| 2024 | 1012.0 |
| 2025 | 1296.9 |
Opportunities · 0612.7% of this theme group
Focuses on remote patient monitoring solutions enabled by wearable sensors and internet‑of‑things platforms.
Wearable computer (117) · Medical device (84) · Remote patient monitoring (76) · Internet of Things (49)
Wearable technology. Health-care solutions for a growing global population.
IoT Based Effective Wearable Healthcare Monitoring System For Remote Areas
| Year | Share index |
|---|---|
| 2022 | 40.5 |
| 2023 | 42.2 |
| 2024 | 44.3 |
| 2025 | 74.3 |
Opportunities · 0712.5% of this theme group
Highlights bioinformatic approaches to identify circulating tumor markers for individualized cancer therapy.
Cancer (241) · Precision medicine (207) · Breast cancer (90) · Lung cancer (44)
Bioinformatics-Based Analysis of Circulating Tumor Cells: A Methodological Overview of Personalized Cancer Treatment
[Molecular biomarkers in breast cancer : advances in precision medicine].
| Year | Share index |
|---|---|
| 2022 | 776.6 |
| 2023 | 1055.1 |
| 2024 | 810.2 |
| 2025 | 787.3 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Promising | 29.7% | 37.2% |
| Problem-identifying | 29.0% | 9.7% |
| Descriptive | 18.8% | 17.5% |
| Breakthrough | 12.7% | 26.2% |
| Cautionary | 6.4% | 4.5% |
| Comparative | 2.5% | 3.9% |
| Critical | 0.9% | 1.0% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceThe future of digital health with federated learning | 4,573 | 2.66% | 2,251 (49.2%) | 2.66% |
| Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media | 292 | 0.17% | 167 (57.2%) | 0.17% |
| Bias & fairnessChallenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fa | 99 | 0.06% | 45 (45.5%) | 0.06% |
| Hardware, e-waste & supply chainE-waste for health: recycling smartphones for health monitoring | 24 | 0.01% | 7 (29.2%) | 0.01% |
| Concentration of compute powerDemonopolizing Medical Knowledge | 16 | 0.01% | 7 (43.8%) | 0.01% |
| Labour & data workNew Work—New Interventions: Digital Occupational Health Interventions and the Co-Creation of a Human-Centered Future of | 11 | 0.01% | 6 (54.5%) | 0.01% |
| Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT | 10 | 0.01% | 4 (40.0%) | 0.01% |
| Carbon & emissions of computeSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re | 3 | 0.0% | 1 (33.3%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.
Published patent filings in the recorded source window.
Company counts, hiring and disclosed funding across the recorded hubs.
42.5% across the displayed hubs
51 companies hiring · $1.4B disclosed funding
Explore companies in Berlin ↗
20.0% across the displayed hubs
27 companies hiring · $657.4M disclosed funding
Explore companies in Munich ↗
15.4% across the displayed hubs
15 companies hiring · $189.9M disclosed funding
Explore companies in Hamburg ↗
5.8% across the displayed hubs
6 companies hiring · $32.4M disclosed funding
Explore companies in Cologne ↗
4.9% across the displayed hubs
4 companies hiring · $2.8M disclosed funding
Explore companies in Dusseldorf ↗
4.0% across the displayed hubs
3 companies hiring · $88.6M disclosed funding
Explore companies in Heidelberg ↗
3.9% across the displayed hubs
7 companies hiring · $913.4K disclosed funding
Explore companies in Karlsruhe ↗
3.6% across the displayed hubs
3 companies hiring · $51.5M disclosed funding
Explore companies in Leipzig ↗Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 31 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗